A trial at this point that hasn't even started yet means a further delay of several months not weeks IMO. I'll reserve my judgement of this development until we get more facts on what the data is for. If its to boost IDE my question is why hv they only now realized this.
My bad. Patients could also include feline or pets, not just human If it works for pet, it should work on human. Btw, that is huge share volume purchased today. Something is brewing and someone knows it before us here on the forum
Market Data 
Markets 
AI
